CYL.AXCYL.AXASX
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+36.8%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+36.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
202542.45%+62.3%
202426.16%+2823.9%
2023-0.96%-105.8%
202216.59%-21.2%
202121.06%-
20200.00%-
20190.00%-
20180.00%-
20170.00%+100.0%
2016-6192.04%-